- Novo Nordisk expands in China and Czech; Cellares boosts Series D by $50MPlus more from Eisai and Siegfried. 🧱 Novo Nordisk's expansions: Novo Nordisk has invested around $380 million to expand its manufacturing facility in Bohumil, Central Bohemia, in the Czech Repu…Endpoints · 1mo ago↗ source
- IRA's Medicare out-of-pocket cap increased access to drugs, study findsMedication usage, particularly for the most expensive drugs, increased significantly shortly after the Medicare annual out-of-pocket cost cap took effect in January 2025, a study published in JAMA…Endpoints · 1mo ago↗ source
- Prepping for peptidesIt wasn’t too many years ago when we were busy theorizing about the market opportunity for GLP-1 weight loss drugs. Now, the big question is the moneymaking potential for other peptides that might…